An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.
Some experts stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at residence.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.
Item Information and Pricing
Within these groups, posts show black plastic parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly serious medical dangers”.
